A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.

Clinical trial NCT06493578 · TERMINATED

Trial details

NCT number: NCT06493578
Sponsor: Vyne Therapeutics Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-segmental Vitiligo

Start date: 2024-06-04
Primary completion: 2025-07-10
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.